Creating a colony-forming unit commonly starts with adding around 15 ml of molten agar to around 1 ml of bacterial culture in ...

Opens in a new tab or window SAN FRANCISCO -- The addition of radionuclide therapy with 177 Lu-PSMA-617 (Pluvicto) to enzalutamide (Xtandi) improved overall survival (OS) in patients with ...

Adding talazoparib to enzalutamide led to a statistically significant and clinically meaningful improvement in overall survival in patients with metastatic castration-resistant prostate cancer ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window SAN FRANCISCO -- Adding talazoparib (Talzenna) to enzalutamide (Xtandi) as initial treatment for metastatic castration ...

Beekeepers are reporting significant colony losses, raising concerns about food security due to potential pollination shortages. While the exact cause of the colony collapses remains unknown ...

The 16th-century map provides insights into the fate of the settlers who formed the so-called Lost Colony of Roanoke. This small settlement of more than 100 English colonists was founded on ...

The plume from Roanoke Island “put us in good hope that some of the colony were there expecting my return out of England,” he wrote later. Three years had passed since the governor had set out ...

The addition of LuPSMA to enzalutamide reduced the risk of death by 45% vs enzalutamide alone. The median OS was 34 months (95% CI, 30-37) with the combination compared to 26 months (95% CI, 23-31) ...

Talazoparib plus enzalutamide boosts overall survival in metastatic castration-resistant prostate cancer, with HRR-deficient patients seeing a 14-month gain and 38% lower death risk. New final overall ...

Mevrometostat combined with enzalutamide improved median rPFS to 14.3 months versus 6.2 months with enzalutamide alone in mCRPC patients. The combination therapy showed a higher objective response ...